The Medicinal Mindfulness Extended-State DMT program (DMTx) was initiated in February 2016 by Daniel McQueen, co-founder of Medicinal Mindfulness. DMTx is based on the cutting edge pharmacokinetic research of Dr. Andrew Gallimore and the revolutionary DMT research of Dr. Rick Strassman. Our DMTx program explores legal psychedelic research and exploration opportunities that are congruent with the needs and interests of the psychedelic community.

Potential applications of Extended-State DMT experiences seem limitless: therapeutic healing, advanced creative problem-solving, consciousness exploration, and explorations in the nature of reality itself.

It is because of the importance of this work that all of us at DMTx wish to share what we are learning with the international psychedelic community and to bring our community into the creation and implementation process of this psychedelic inspired program.

All technical logistics associated with the DMTx program have been resolved and we are ready to step into our first expedition. Our current emphasis is now on fundraising and exploring the few remaining legal hurdles to implement the full DMTx program.

Our first DMTx Psychonaut Cohort was selected in 2018, and have completed two DMTx training retreats, DMTx1 in September 2018, and DMTx2 in September 2019. DMTx3 in Costa Rica, scheduled for the summer of 2020, was cancelled due to the coronavirus. We are currently regrouping and considering a new path to DMTx and will initiate a new version of DMTx3 in the summer of 2021.

We are upgrading our online training protocol to prepare for the second DMTx psychonaut cohort. More information is coming soon.

If you are interested in joining the DMTx program, continue reading below.